(Q43628533)

English

Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Cleland JL

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Duenas ET

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Park A

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Daugherty A

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kahn J

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kowalski J

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cuthbertson A

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of Controlled Release

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1-3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

13-24

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

VEGF administration in chronic myocardial ischemia in pigs

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension and endothelial dysfunction in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The delivery of angiogenic factors to the heart by microsphere therapy

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A month-long effect from a single injection of microencapsulated human growth hormone

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The stabilization and encapsulation of human growth hormone into biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the rates of deamidation, diketopiperazine formation and oxidation in recombinant human vascular endothelial growth factor and model peptides.

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biocompatible controlled release polymers for delivery of polypeptides and growth factors

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2)

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo comparison of bulk and surface hydrolysis in absorbable polymer scaffolds for tissue engineering

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(01)00258-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-3659(01)00258-9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43628533&oldid=2101978563"